Arkolith/Insider Trading/CORT/Form 4

Mokari Atabak

Chief Financial OfficerCORCEPT THERAPEUTICS INC (CORT) · full profile →Form 4 · filed Jun 17, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3.2M
Net Open-Market Flow
-$3.2M
Transactions
6
5 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 15, 2026Option exercise(M)40K$19.26$770K56K
Jun 15, 2026Sell(S)9K$80.02$755K47K
Jun 15, 2026Sell(S)11K$80.94$897K36K
Jun 15, 2026Sell(S)19K$81.81$1.6M16K
Jun 15, 2026Sell(S)2$82.45$16516K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 15, 2026Option exercise(M)40K—$020K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-274224) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for CORCEPT THERAPEUTICS INC

Build

Ask your agent about CORT insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001193125-26-274224"
Ask your agent
Use Arkolith to summarize insider buying and selling at CORCEPT THERAPEUTICS INC
over the last 90 days and cite the filings.